Who Buys Ceftazidime from India — 360 Importers Behind a $10.7M Market
India's ceftazidime import market is served by 360 active buyers who collectively imported $10.7M across 920 shipments. OA&J PHARMACEUTICALS LTD. (GHANA) leads with a 19.0% market share, followed by ANANTA MEDICARE UKRAINE LTD. and ANANTA MEDICARE UKRAINE LIMITED. The top 5 buyers together control 37.2% of total import value, reflecting a moderately competitive buyer landscape.
Ceftazidime buyer data — 360 importers · $10.7M market · 920 shipmentsTransData Nexus · Indian Customs Data
Top Ceftazidime Importers — Ranked by Import Value
OA&J PHARMACEUTICALS LTD. (GHANA) is the leading ceftazidime importer from India, holding a 19.0% share of the $10.7M market across 920 shipments from 360 buyers. The top 5 buyers — OA&J PHARMACEUTICALS LTD. (GHANA), ANANTA MEDICARE UKRAINE LTD. (UKRAINE), ANANTA MEDICARE UKRAINE LIMITED (UKRAINE), BIOMEDIC HEALTHCARE SOLUTION (MYANMAR), E P H K (HUNGARY) — collectively control 37.2% of total import value.
Top Ceftazidime Buyers & Importers
Ranked by import value · 360 active buyers · Indian Customs (DGFT) data
Mar 2026
Top Ceftazidime Buyers & Importers — Ranked by Import Value. 360 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
Which companies are buying Ceftazidime — and from which countries?
Flow of Ceftazidime exports from India: each country's share and the named importers behind the numbers
Ceftazidime — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Top 5 importing countries account for 49.4% of global Ceftazidime imports — led by Ghana (19.5%) with a total trade value of $10.7M across 920 shipments from India.
Market Analysis: Top Importing Countries & Their Importers
1Ghana
Ghana emerges as the first largest importing country, achieving a total trade value of $2.1M through 3 shipments. This represents a market share of 19.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Ghana has a diverse importer base, with their top importers including:
• OA&J PHARMACEUTICALS LTD. - $2.0M (97.2% of country's total business)
Key Insight: Ghana demonstrates strong market positioning with an average shipment value of $694.5K, indicating premium pricing strategy compared to the market average of $11.6K.
Ghana is a key market for Ceftazidime imports, representing 19.5% of total trade value.
Primary Market
Secondary Market
2Ukraine
Ukraine emerges as the second largest importing country, achieving a total trade value of $1.5M through 18 shipments. This represents a market share of 14.3% of the total market activity, demonstrating their significant presence in the industry.
Ukraine has a diverse importer base, with their top importers including:
1Drug Regulatory Authority: Food and Drugs Authority (FDA) Ghana.
2Import Registration Process for Ceftazidime: Importers must register the product with the FDA Ghana, providing comprehensive documentation, including a Certificate of Analysis and Good Manufacturing Practice (GMP) certification.
3Estimated Timeline for Registration: Approximately 3-6 months, depending on the completeness of the application.
4Import Tariff/Duty for HS 30042019: Typically around 5%, but subject to change based on government policies.
Ukraine
1Drug Regulatory Authority: State Service of Ukraine on Medicines and Drugs Control (SMDC).
The demand for Ceftazidime, a third-generation cephalosporin antibiotic, is primarily driven by the prevalence of severe bacterial infections, including hospital-acquired pneumonia and sepsis. In countries like Ghana and Nigeria, high incidences of such infections necessitate robust antibiotic procurement. Government healthcare programs aiming to combat antimicrobial resistance and improve infection control further bolster demand.
The inclusion of Ceftazidime in the World Health Organization's Essential Medicines List underscores its critical role in healthcare systems. This designation often leads to its procurement through international tenders and funding from global health initiatives. The expansion of universal health coverage in nations like Myanmar and Sudan enhances access to essential antibiotics, presenting significant market opportunities for suppliers.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Common Questions — Ceftazidime Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest ceftazidime buyer importing from India?
Based on import volume and value, OA&J PHARMACEUTICALS LTD. (GHANA) leads with $2.0M in imports and a 19.0% market share — the highest of any single ceftazidime importer. ANANTA MEDICARE UKRAINE LTD. (UKRAINE) and ANANTA MEDICARE UKRAINE LIMITED (UKRAINE) are the next largest buyers.
QHow many companies buy ceftazidime from India?
There are 360 active ceftazidime buyers importing from India, with a combined market of $10.7M across 920 shipments to 99 countries. The top 5 buyers hold 37.2% of total import value, while the remaining 355 buyers handle the other 62.8%.
QWhich countries import the most ceftazidime from India?
The top importing countries for ceftazidime from India are Ghana (19.5%), Ukraine (14.3%), Sudan (8.0%), France (3.9%), Myanmar (3.7%). These markets represent the largest demand centres for Indian pharmaceutical exports of ceftazidime, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for ceftazidime from India?
The average import transaction value for ceftazidime from India is $11.6K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
1Drug Regulatory Authority: Food and Drugs Authority (FDA) Ghana.
2Import Registration Process for Ceftazidime: Importers must register the product with the FDA Ghana, providing comprehensive documentation, including a Certificate of Analysis and Good Manufacturing Practice (GMP) certification.
3Estimated Timeline for Registration: Approximately 3-6 months, depending on the completeness of the application.
4Import Tariff/Duty for HS 30042019: Typically around 5%, but subject to change based on government policies.
Ukraine
1Drug Regulatory Authority: State Service of Ukraine on Medicines and Drugs Control (SMDC).
The demand for Ceftazidime, a third-generation cephalosporin antibiotic, is primarily driven by the prevalence of severe bacterial infections, including hospital-acquired pneumonia and sepsis. In countries like Ghana and Nigeria, high incidences of such infections necessitate robust antibiotic procurement. Government healthcare programs aiming to combat antimicrobial resistance and improve infection control further bolster demand.
The inclusion of Ceftazidime in the World Health Organization's Essential Medicines List underscores its critical role in healthcare systems. This designation often leads to its procurement through international tenders and funding from global health initiatives. The expansion of universal health coverage in nations like Myanmar and Sudan enhances access to essential antibiotics, presenting significant market opportunities for suppliers.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Top Importers:
• ANANTA MEDICARE UKRAINE LTD. - $1.2M (78.9% of country's total business)
• ANANTA MEDICARE UKRAINE LIMITED - $362.0K (23.7% of country's total business)
Key Insight: Ukraine demonstrates strong market positioning with an average shipment value of $84.8K, indicating premium pricing strategy compared to the market average of $11.6K.
Ukraine is a key market for Ceftazidime imports, representing 14.3% of total trade value.
Primary Market
Secondary Market
3Sudan
Sudan emerges as the third largest importing country, achieving a total trade value of $850.9K through 3 shipments. This represents a market share of 8.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Sudan has a diverse importer base, with their top importers including:
• TO THE DIRECTOR OF - $100.5K (11.8% of country's total business)
Key Insight: Sudan demonstrates strong market positioning with an average shipment value of $283.6K, indicating premium pricing strategy compared to the market average of $11.6K.
Sudan is a key market for Ceftazidime imports, representing 8.0% of total trade value.
Primary Market
Secondary Market
4France
France emerges as the fourth largest importing country, achieving a total trade value of $416.6K through 17 shipments. This represents a market share of 3.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: France has a diverse importer base, with their top importers including:
• PLANETPHARMA SA - $129.0K (31.0% of country's total business)
• DISTRIMEX. - $95.0K (22.8% of country's total business)
• DISTRIMEX PARC LOGISTIQUE DU PONT DE - $91.5K (22.0% of country's total business)
Key Insight: France demonstrates strong market positioning with an average shipment value of $24.5K, indicating premium pricing strategy compared to the market average of $11.6K.
France is a key market for Ceftazidime imports, representing 3.9% of total trade value.
Primary Market
Secondary Market
5Myanmar
Myanmar emerges as the fifth largest importing country, achieving a total trade value of $397.4K through 4 shipments. This represents a market share of 3.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Myanmar has a diverse importer base, with their top importers including:
• BIOMEDIC HEALTHCARE SOLUTION - $201.3K (50.7% of country's total business)
Key Insight: Myanmar demonstrates strong market positioning with an average shipment value of $99.3K, indicating premium pricing strategy compared to the market average of $11.6K.
Myanmar is a key market for Ceftazidime imports, representing 3.7% of total trade value.
Primary Market
Secondary Market
Contract Manufacturers: Firms importing active pharmaceutical ingredients for local production.
Analyzing the top 10 buyers:
1OA&J Pharmaceuticals Ltd. (Ghana, $2.03M): Likely a distributor supplying to various healthcare facilities.
2Ananta Medicare Ukraine Ltd. (Ukraine, $1.20M) and Ananta Medicare Ukraine Limited (Ukraine, $0.36M): Possibly distributors or contract manufacturers, given the significant volumes.
3Biomedic Healthcare Solution (Myanmar, $0.20M): Potentially a distributor or retail chain.
4E P H K (Hungary, $0.17M): Could be a distributor or re-exporter.
5OOO Jodas Expoim (Russia, $0.14M): Likely a distributor.
6V P G (Germany, $0.14M): Possibly a distributor or re-exporter.
7Planetpharma SA (France, $0.13M): Likely a distributor.
8Precious Trust Ltd. (Nigeria, $0.12M): Potentially a distributor.
9To the Receiving Department (South Africa, $0.12M): Could be a hospital group or distributor.
Distributors typically place large, periodic orders to maintain inventory levels, aligning with the repeat buyer rate of 44.7%. Hospital groups and retail chains may order more frequently but in smaller quantities, depending on patient demand. Government procurement entities often engage in tender-based purchasing, leading to bulk orders at specific intervals. Re-exporters and contract manufacturers' purchasing patterns vary based on market demands and production schedules.
TransData Nexus Research · Government and regulatory sourcesMar 2026
2Import Registration Process for Ceftazidime: Importers must obtain a license from the SMDC, ensuring compliance with Good Distribution Practice (GDP) and Good Manufacturing Practice (GMP) standards. (cratia.ua)
3Estimated Timeline for Registration: Approximately 6 months, contingent on the application's accuracy and completeness.
4Import Tariff/Duty for HS 30042019: Generally around 10%, but subject to periodic revisions.
Sudan
1Drug Regulatory Authority: National Medicines and Poisons Board (NMPB).
2Import Registration Process for Ceftazidime: Requires product registration with the NMPB, including submission of quality documentation and adherence to local pharmaceutical standards.
3Estimated Timeline for Registration: Approximately 4-8 months, depending on the review process.
4Import Tariff/Duty for HS 30042019: Typically around 5%, but subject to governmental adjustments.
France
1Drug Regulatory Authority: Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM).
2Import Registration Process for Ceftazidime: Requires a Marketing Authorization (MA) from ANSM, involving submission of comprehensive clinical and quality data.
3Estimated Timeline for Registration: Approximately 12-18 months, reflecting the rigorous evaluation process.
4Import Tariff/Duty for HS 30042019: As an EU member, France applies the EU's Common External Tariff, typically around 0-6% for pharmaceuticals.
Myanmar
1Drug Regulatory Authority: Food and Drug Administration (FDA) Myanmar.
2Import Registration Process for Ceftazidime: Importers must register the product with FDA Myanmar, providing necessary documentation, including GMP certification and product samples.
3Estimated Timeline for Registration: Approximately 6-12 months, subject to the review process.
4Import Tariff/Duty for HS 30042019: Typically around 5%, but subject to change based on government policies.
TransData Nexus Research · Government and regulatory sourcesMar 2026
$17.38 per unit
Contract Manufacturers: Firms importing active pharmaceutical ingredients for local production.
Analyzing the top 10 buyers:
1OA&J Pharmaceuticals Ltd. (Ghana, $2.03M): Likely a distributor supplying to various healthcare facilities.
2Ananta Medicare Ukraine Ltd. (Ukraine, $1.20M) and Ananta Medicare Ukraine Limited (Ukraine, $0.36M): Possibly distributors or contract manufacturers, given the significant volumes.
3Biomedic Healthcare Solution (Myanmar, $0.20M): Potentially a distributor or retail chain.
4E P H K (Hungary, $0.17M): Could be a distributor or re-exporter.
5OOO Jodas Expoim (Russia, $0.14M): Likely a distributor.
6V P G (Germany, $0.14M): Possibly a distributor or re-exporter.
7Planetpharma SA (France, $0.13M): Likely a distributor.
8Precious Trust Ltd. (Nigeria, $0.12M): Potentially a distributor.
9To the Receiving Department (South Africa, $0.12M): Could be a hospital group or distributor.
Distributors typically place large, periodic orders to maintain inventory levels, aligning with the repeat buyer rate of 44.7%. Hospital groups and retail chains may order more frequently but in smaller quantities, depending on patient demand. Government procurement entities often engage in tender-based purchasing, leading to bulk orders at specific intervals. Re-exporters and contract manufacturers' purchasing patterns vary based on market demands and production schedules.
TransData Nexus Research · Government and regulatory sourcesMar 2026
2Import Registration Process for Ceftazidime: Importers must obtain a license from the SMDC, ensuring compliance with Good Distribution Practice (GDP) and Good Manufacturing Practice (GMP) standards. (cratia.ua)
3Estimated Timeline for Registration: Approximately 6 months, contingent on the application's accuracy and completeness.
4Import Tariff/Duty for HS 30042019: Generally around 10%, but subject to periodic revisions.
Sudan
1Drug Regulatory Authority: National Medicines and Poisons Board (NMPB).
2Import Registration Process for Ceftazidime: Requires product registration with the NMPB, including submission of quality documentation and adherence to local pharmaceutical standards.
3Estimated Timeline for Registration: Approximately 4-8 months, depending on the review process.
4Import Tariff/Duty for HS 30042019: Typically around 5%, but subject to governmental adjustments.
France
1Drug Regulatory Authority: Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM).
2Import Registration Process for Ceftazidime: Requires a Marketing Authorization (MA) from ANSM, involving submission of comprehensive clinical and quality data.
3Estimated Timeline for Registration: Approximately 12-18 months, reflecting the rigorous evaluation process.
4Import Tariff/Duty for HS 30042019: As an EU member, France applies the EU's Common External Tariff, typically around 0-6% for pharmaceuticals.
Myanmar
1Drug Regulatory Authority: Food and Drug Administration (FDA) Myanmar.
2Import Registration Process for Ceftazidime: Importers must register the product with FDA Myanmar, providing necessary documentation, including GMP certification and product samples.
3Estimated Timeline for Registration: Approximately 6-12 months, subject to the review process.
4Import Tariff/Duty for HS 30042019: Typically around 5%, but subject to change based on government policies.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Analysis Methodology
1.Buyer Identification: 360 global importers of Ceftazidime identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 920 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 99 destination countries with market share per buyer calculated from capped values.
